(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -0.13% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.03%.
Neogen's revenue in 2026 is $883,991,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $196,658,807,669, with the lowest NEOG revenue forecast at $188,673,172,945, and the highest NEOG revenue forecast at $202,839,051,491. On average, 7 Wall Street analysts forecast NEOG's revenue for 2028 to be $192,757,678,841, with the lowest NEOG revenue forecast at $175,965,578,706, and the highest NEOG revenue forecast at $208,301,068,462.
In 2029, NEOG is forecast to generate $180,163,603,740 in revenue, with the lowest revenue forecast at $173,099,220,479 and the highest revenue forecast at $185,464,074,245.